← All stocks

LEXICON PHARMACEUTICALS, INC.

LXRX No buying or selling

CIK 0001062822 #2543 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

19 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Artal Participations S.a r.l.

Director

—

175,156,062

$260.98M

+13.2%

DEBBANE RAYMOND

Director

—

1,995,498

$2.97M

+47.9%

Invus Global Management, LLC entity

Director

—

1,538,462

$2.29M

—

Crum Brian T

SVP, General Counsel & Secr.

—

428,802

$638.91K

+141.6%

Amouyal Philippe

Director

—

374,486

$557.98K

+50.8%

MAIN ALAN J

EVP, Innov & Chem Sciences

—

339,104

$505.26K

+32.6%

Granowitz Craig B

SVP, Chief Medical Officer

—

323,430

$481.91K

+579.1%

Exton Michael

Chief Executive Officer

—

298,432

$444.66K

—

SOBECKI CHRISTOPHER J

Director

—

293,177

$436.83K

+75.5%

McDermott Wendy

SVP, Human Resources

—

277,945

$414.14K

+427.5%

BARKER SAM L

Director

—

213,771

$318.52K

+143.9%

Swain Judith L

Director

—

174,486

$259.98K

+260.8%

Gopinathan Suma

SVP, Discovery

—

150,132

$223.70K

+101.5%

Sullivan Diane E.

Director

—

126,122

$187.92K

—

Coiante Scott M

SVP, Chief Financial Officer

—

105,356

$156.98K

—

DeFrancesco Lisa

SVP, IR and Corp Comm

—

93,869

$139.86K

—

Cheung Ivan

Director

—

89,312

$133.07K

—

Alexander Kristen

VP, Finance and Accounting

—

76,368

$113.79K

+59.8%

Martens Rachel Yap

SVP, Partnerships & Corp Strat

—

31,264

$46.58K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

LEXICON PHARMACEUTICALS, INC.

By person

Individual transactions

What was left out